Silverfin false false 31/10/2024 01/11/2023 31/10/2024 A De Pape 24 October 2025 The principal activity of the company continued to be that of developing an online community for training. 08258305 2024-10-31 08258305 2023-10-31 08258305 core:CurrentFinancialInstruments 2024-10-31 08258305 core:CurrentFinancialInstruments 2023-10-31 08258305 core:ShareCapital 2024-10-31 08258305 core:ShareCapital 2023-10-31 08258305 core:SharePremium 2024-10-31 08258305 core:SharePremium 2023-10-31 08258305 core:OtherCapitalReserve 2024-10-31 08258305 core:OtherCapitalReserve 2023-10-31 08258305 core:RetainedEarningsAccumulatedLosses 2024-10-31 08258305 core:RetainedEarningsAccumulatedLosses 2023-10-31 08258305 core:ComputerEquipment 2023-10-31 08258305 core:ComputerEquipment 2024-10-31 08258305 2023-11-01 2024-10-31 08258305 bus:FilletedAccounts 2023-11-01 2024-10-31 08258305 bus:SmallEntities 2023-11-01 2024-10-31 08258305 bus:AuditExemptWithAccountantsReport 2023-11-01 2024-10-31 08258305 bus:PrivateLimitedCompanyLtd 2023-11-01 2024-10-31 08258305 bus:Director1 2023-11-01 2024-10-31 08258305 core:ComputerEquipment core:TopRangeValue 2023-11-01 2024-10-31 08258305 2022-11-01 2023-10-31 08258305 core:ComputerEquipment 2023-11-01 2024-10-31 iso4217:GBP xbrli:pure

Company No: 08258305 (England and Wales)

# ASWEGROW LIMITED

### Unaudited Financial Statements
For the financial year ended 31 October 2024
Pages for filing with the registrar

ASWEGROW LIMITED

## Unaudited Financial Statements

For the financial year ended 31 October 2024

Contents

ASWEGROW LIMITED

## COMPANY INFORMATION

For the financial year ended 31 October 2024
ASWEGROW LIMITED

## COMPANY INFORMATION (continued)

For the financial year ended 31 October 2024

DIRECTOR | A De Pape

REGISTERED OFFICE | 2 Leman Street
| London
| E1W 9US
| United Kingdom

COMPANY NUMBER | 08258305 (England and Wales)

ACCOUNTANT | Gravita Business Services II Limited
| Aldgate Tower
| 2 Leman Street
| London
| E1 8FA
| United Kingdom

ASWEGROW LIMITED

## BALANCE SHEET

As at 31 October 2024
ASWEGROW LIMITED

## BALANCE SHEET (continued)

As at 31 October 2024

| Note | 2024 |  | 2023
|  | £ |  | £
Fixed assets |  |  |  |
Tangible assets | 3 | 425 |  | 3,650
|  | 425 |  | 3,650
Current assets |  |  |  |
Debtors | 4 | 11,197 |  | 19,074
Cash at bank and in hand |  | 14,909 |  | 16,390
|  | 26,106 |  | 35,464
Creditors: amounts falling due within one year | 5 | ( 54,047) |  | ( 52,898)
Net current liabilities |  | (27,941) |  | (17,434)
Total assets less current liabilities |  | (27,516) |  | (13,784)
Net liabilities |  | ( 27,516) |  | ( 13,784)
Capital and reserves |  |  |  |
Called-up share capital |  | 129 |  | 129
Share premium account |  | 859,660 |  | 859,660
Other reserves |  | 137,358 |  | 137,358
Profit and loss account |  | ( 1,024,663 ) |  | ( 1,010,931 )
Total shareholders' deficit |  | ( 27,516) |  | ( 13,784)

For the financial year ending 31 October 2024 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

- The members have not required the Company to obtain an audit of its financial statements for the financial year in accordance with section 476;
- The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements; and
- These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime and a copy of the Statement of Income and Retained Earnings has not been delivered.

The financial statements of Aswegrow Limited (registered number: 08258305) were approved and authorised for issue by the Director on 24 October 2025. They were signed on its behalf by:

A De Pape Director |

ASWEGROW LIMITED

## NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 October 2024
ASWEGROW LIMITED

## NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 October 2024

##### 1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

##### General information and basis of accounting

Aswegrow Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is 2 Leman Street, London, United Kingdom, E1W 9US.
The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.
The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

##### Going concern

At the time of approving the financial statements, the director has a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the director continues to adopt the going concern basis of accounting in preparing the financial statements.

##### Foreign currency

Transactions in foreign currencies are recorded at the rate of exchange at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies at the Balance Sheet date are reported at the rates of exchange prevailing at that date.
Exchange differences are recognised in the Statement of Income and Retained Earnings in the period in which they arise except for exchange differences arising on gains or losses on non-monetary items which are recognised in the Statement of Comprehensive Income.

##### Turnover

Turnover is recognised at the fair value of the consideration received or receivable for services provided in the normal course of business, and is shown net of VAT and other sales related taxes where applicable.

##### Research and development expenditure

Research and development expenditure is written off to the profit and loss account in the year in which it is incurred unless the director is satisfied as to the technical, commercial and financial viability of individual projects. In this situation, the expenditure is deferred and amortised over the period during which the company is expected to benefit.

##### Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Computer equipment | 3 years straight line

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

##### Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.
Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Financial assets are derecognised when and only when the contractual rights to the cash flows from the financial asset expire or are settled, or the Company transfers to another party substantially all of the risks and rewards of ownership of the financial asset, or the Company, despite having retained some, but not all, significant risks and rewards of ownership, has transferred control of the asset to another party.

Basic financial liabilities
Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.

Equity instruments
Equity instruments issued by the Company are recorded at the fair value of cash or other resources received or receivable, net of direct issue costs. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the Company.

#### 2. Employees

| 2024 |  | 2023
| Number |  | Number
Monthly average number of persons employed by the Company during the year, including the director | 1 |  | 1

#### 3. Tangible assets

| Computer equipment |  | Total
| £ |  | £
Cost |  |  |
At 01 November 2023 | 16,488 |  | 16,488
At 31 October 2024 | 16,488 |  | 16,488
Accumulated depreciation |  |  |
At 01 November 2023 | 12,838 |  | 12,838
Charge for the financial year | 3,225 |  | 3,225
At 31 October 2024 | 16,063 |  | 16,063
Net book value |  |  |
At 31 October 2024 | 425 |  | 425
At 31 October 2023 | 3,650 |  | 3,650

#### 4. Debtors

| 2024 |  | 2023
| £ |  | £
Other debtors | 11,197 |  | 19,074

#### 5. Creditors: amounts falling due within one year

| 2024 |  | 2023
| £ |  | £
Trade creditors | 10,527 |  | 6,401
Other taxation and social security | 11,277 |  | 10,931
Other creditors | 32,243 |  | 35,566
| 54,047 |  | 52,898

#### 6. Related party transactions

At the year end the company owed £19,483 to (2023 - was owed £7,487 by) the director of the company, in respect of an interest free loan repayable on demand.
During the year, the company received fees of £38,168 (2023 - £24,792) from Genomesio Limited, a company under common control of the director.